Tell your friends about this item:
The Challenge of CMC Regulatory Compliance for Biopharmaceuticals John Geigert Fifth Edition 2026 edition
Price
NZ$ 312.50
excl. VAT
Ordered from remote warehouse
Expected delivery Sep 14 - 24
Get notified about new John Geigert releases
Add to your iMusic wish list
Also available as:
-
Paperback BookFourth Edition 2023 edition(2024) NZ$ 278.50
-
Hardcover BookThird Edition 2019 edition(2019) NZ$ 278.50
-
Paperback BookSecond Edition 2013 edition(2016) NZ$ 312.50
-
Hardcover Book2004 edition(2003) NZ$ 355.50
-
Paperback BookSoftcover reprint of the original 1st ed. 2004 edition(2012) NZ$ 355.50
-
Hardcover BookSecond Edition 2013 edition(2013) NZ$ 431
The Challenge of CMC Regulatory Compliance for Biopharmaceuticals
John Geigert
Regulatory authorities, primarily the U.S. FDA and the European EMA, have responded to this increasing CMC regulatory compliance complexity of biopharmaceuticals, and have issued over 150 new or updated regulatory guidelines since the publishing of the previous edition.
| Media | Books Hardcover Book (Book with hard spine and cover) |
| Released | July 3, 2026 |
| ISBN13 | 9783032252821 |
| Publishers | Springer Nature Switzerland AG |
| Pages | 629 |
| Dimensions | 150 × 220 × 20 mm · 1.14 kg |
| Language | German |